Allogeneic Stem Cell Transplantation for Myelofibrosis and Myelodysplastic Syndrome
Status:
Completed
Trial end date:
2017-10-04
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if using a combination of fludarabine,
busulfan, and antithymocyte globulin (ATG) can help to control myelofibrosis or
myelodysplastic syndrome in patients receiving a bone marrow or blood stem cell transplant.
The safety of these drugs will also be studied.